Expected CMS Payment Demos Could Shift Locus Of Part D Drug Purchasing
Executive Summary
Future demonstration projects by the Center for Medicare and Medicaid Innovation are likely to experiment with shifting drug purchasing decisions from Medicare Part D plans to health care providers such as hospitals, large health clinics or multi-specialty physician practices
You may also be interested in...
One To Watch: CMS Innovation Center Gets Chief, High-Priority Focus
The new payment innovation center at the Centers for Medicare and Medicaid Services is shaping up as a high-priority program for the agency, as demonstrated by the recent appointment of former Geisinger executive Richard Gilfillan to head the unit.
One To Watch: CMS Innovation Center Gets Chief, High-Priority Focus
The new payment innovation center at the Centers for Medicare and Medicaid Services is shaping up as a high-priority program for the agency, as demonstrated by the recent appointment of former Geisinger executive Richard Gilfillan to head the unit.
Berwick’s Call To Action: CMS Needs Industry Partners With “Authentic” Aims
The Centers for Medicare and Medicaid Services is seeking stakeholder collaboration to implement health care reforms but will only work with partners dedicated to true change, CMS Administrator Donald Berwick asserted at the America’s Health Insurance Plans Medicare conference in Washington, D.C., Sept. 13.